Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Genprex Inc (GNPX)

Genprex Inc (GNPX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Genprex to Participate in Upcoming March Investor Conferences

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that it will...

GNPX : 5.38 (+4.26%)
Genprex, Inc. Announces $25 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules, Without Warrants

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced it has entered...

GNPX : 5.38 (+4.26%)
Genprex Announces Formation of Clinical Advisory Board

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the...

GNPX : 5.38 (+4.26%)
Small and Microcap Company Investor Presentations Now Available for On-Demand Viewing

, /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the Small and Microcap Showcase are now available for...

BIGG.CN : 1.300 (+10.17%)
NTAR.CN : 5.300 (+4.13%)
MIRI.LN : 52.000 (unch)
BBKCF : 1.0264 (+11.57%)
EXPFF : 0.3325 (+15.13%)
MMDDF : 0.6970 (+2.50%)
NEXCF : 4.1724 (+4.31%)
ALVOF : 0.6500 (-7.14%)
ETIHY : 3.6000 (+18.42%)
LLEIF : 7.9300 (unch)
GNPX : 5.38 (+4.26%)
BSGM : 4.50 (+1.12%)
VNRX : 4.18 (+2.45%)
CTXR : 2.08 (+2.46%)
VERB : 2.28 (unch)
LGIQ : 7.3900 (-1.47%)
CETY : 0.0851 (-1.05%)
SLBG : 2.9000 (-9.38%)
SKYE : 0.0862 (-21.28%)
Genprex Recognizes World Cancer Day

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announces today that...

GNPX : 5.38 (+4.26%)
Genprex Issues Shareholder Letter and Provides Corporate Update

--Company looks toward launching key clinical trials in lung cancer in 2021

GNPX : 5.38 (+4.26%)
Live Investor Conference & Webinar: Small and Microcap Company Showcase on February 4th

, /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming Small and Microcap Showcase.  Individual investors, institutional...

VNRX : 4.18 (+2.45%)
BIGG.CN : 1.300 (+10.17%)
MIRI.LN : 52.000 (unch)
BSGM : 4.50 (+1.12%)
GNPX : 5.38 (+4.26%)
VERB : 2.28 (unch)
CTXR : 2.08 (+2.46%)
EMBI : 0.0900 (+1.69%)
SKYE : 0.0862 (-21.28%)
BBKCF : 1.0264 (+11.57%)
CETY : 0.0851 (-1.05%)
EXPFF : 0.3325 (+15.13%)
MMDDF : 0.6970 (+2.50%)
SLBG : 2.9000 (-9.38%)
ALVOF : 0.6500 (-7.14%)
ETIHY : 3.6000 (+18.42%)
LGIQ : 7.3900 (-1.47%)
LLEIF : 7.9300 (unch)
Genprex to Present at the Virtual Investor Conference Small and Microcap Showcase on February 4

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that...

GNPX : 5.38 (+4.26%)
Genprex to Present its Cutting-Edge Gene Therapies at the MoneyShow Accredited Investors Virtual Expo

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that...

GNPX : 5.38 (+4.26%)
Genprex to Present at NobleCon17 on January 19

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that...

GNPX : 5.38 (+4.26%)
Genprex Achieves Major Manufacturing Milestone for REQORSA(TM) Immunogene Therapy for Upcoming Trials to Treat Non-Small Cell Lung Cancer

Genprex, Inc. ("Genprex" or the "Company") (Nasdaq: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced today that...

GNPX : 5.38 (+4.26%)
Genprex, Inc. Announces Closing Of $12 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Without Warrants

Genprex, Inc. (Nasdaq: GNPX) ("Genprex" or the "Company"), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the...

GNPX : 5.38 (+4.26%)
Genprex, Inc. Announces $12 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules, Without Warrants

Genprex, Inc. (Nasdaq: GNPX) ("Genprex" or the "Company"), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it...

GNPX : 5.38 (+4.26%)
Genprex Completes Manufacturing Scale-Up for Clinical-Grade Production of REQORSA(TM) Immunogene Therapy for Upcoming Acclaim-1 and Acclaim-2 Clinical Trials For Lung Cancer

--Achievement Highlighted by Important Process Improvements and Significantly Improved Economies of Scale

GNPX : 5.38 (+4.26%)
Genprex (GNPX) Looks Good: Stock Adds 6.5% in Session

Genprex (GNPX) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

RGEN : 221.73 (+4.40%)
GNPX : 5.38 (+4.26%)
Genprex Completes Manufacturing Technology Transfer for Novel Gene Therapy

--Manufacturing Technology Transfer Marks Major Company Milestone

GNPX : 5.38 (+4.26%)
Genprex to Present at the Benzinga Global Small Cap Conference on December 8

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that...

GNPX : 5.38 (+4.26%)
Genprex Initiates Site Recruitment for Acclaim-1 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer

--Company expects to recruit approximately 10 sites across the United States

GNPX : 5.38 (+4.26%)
Genprex to Participate at the Diamond Equity Research Emerging Growth Invitational on December 1

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that...

GNPX : 5.38 (+4.26%)
Genprex to Participate in Panel at Life Sciences Summit on November 17

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that...

GNPX : 5.38 (+4.26%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar